Movement Disorders
News
Isradipine Shows No Benefit for Parkinson’s Disease
Friday, May 03, 2019—A study of the blood pressure drug isradipine does not show benefit for people with Parkinson’s disease, according to findings that will be presented at the America…
Last Patient Fully Assessed in Trial of Accordion Formulation of Levodopa/Carbidopa for Parkinson’s Disease
Thursday, May 02, 2019—The final patient completed their last physician visit in a pivotal phase 3 clinical trial for the accordion pill formulation of carbidopa/levodopa (AP-CD/LD) (Intec Pharma, J…
Young Blood Plasma for Parkinson's Disease
Wednesday, May 01, 2019—Results of a clinical trial that administered blood plasma from donors, age 18 to 25 years, into individuals with Parkinson's disease resulted in significant improvem…
Phase 2 Study of Oral Treatment for Essential Tremor
Thursday, April 25, 2019—A small molecule T-type calcium channel inhibitor (CX-8998; Cavion, Charlottesville, VA) is showing signs of efficacy for treatment of essential tremor. Using the Tremor Resea…
$1.5 Million in Community Grant Funding from The Parkinson’s Foundation
Tuesday, April 23, 2019—More than $1.5 million in community grants from The Parkinson's Foundation were announced. The grants will support education, wellness, and local health programs that addr…
Research Agenda Created for Women Living with Parkinson's Disease
Wednesday, April 17, 2019—The Parkinson's Foundation Women and Parkinson’s Initiativeis the first patient-centered action agenda for improving quality of life for women with Parkinson…
Technology Has Potential to Halt Production of Mutated Protein in Huntington’s Disease and Spinocerebellar Ataxia
Monday, April 08, 2019—Early data supports a potential therapy for neurodegenerative diseases such as Huntington’s disease (HD) and spinocerebellar ataxia (SCA) that are caused by trinucleotid…
New Drug Application Resubmitted for Istradefylline for Parkinson’s Disease OFF Periods
Ia
Friday, April 05, 2019—A new drug application has been resubmitted to the Food and Drug Administration (FDA) for istradefylline (KW-6002; Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan). Istradefylline h…
